1
0
0
(1 - 31 von 33
)
Pinpointing Mutations in a Relapsed Cancer May Lead to Better...
www.chop.edu
CHOP neuroblastoma researchers have detailed how cancer-driving mutations evolve during chemotherapy, and they aim to exploit this knowledge to design better...
Pinpointing Mutations in a Relapsed Children's Cancer May Point to...
www.prnewswire.com
-- CHOP Experts: Neuroblastoma Mutations that Drive Relapse May Also Open Pathway to Precision Medicine--
Leadership | International Neuroblastoma Risk Group Task ...inrgdb.org › about › leadership
inrgdb.org
Gudrun Schleiermacher, MD, PhD. Pediatric Oncologist / Physician-Scientist Department of Pediatric Oncology Translational Research in Pediatric Oncology ...
Emergence of new ALK mutations at relapse of neuroblastoma
biblio.ugent.be
Gudrun Schleiermacher, Niloufar Javanmardi, Virginie Bernard, Quentin Leroy, Julie Cappo, Thomas Rio Frio, Gaëlle Pierron, Eve Lapouble, ...
PLOS ONE: Radiogenomics of neuroblastomas: Relationships between...
journals.plos.org
Gudrun Schleiermacher. Roles Conceptualization, Formal analysis, Funding acquisition, Investigation, Methodology, Resources, Validation, ...
Encyclopedia of Cancer - Google Books
books.google.nl
Neuroblastoma: Diagnosis and Treatment 1 Gudrun Schleiermacher and Thierry Philip Neuroblastoma: Pathology and Genetics Nai-Kong V Cheung and ...
Neuroblastoma: Clinical and Surgical Management - Google Books
books.google.nl
This book addresses neuroblastoma, a type of embryonic tumor derived from neural crest cells and one of the most frequent extra-cranial solid tumors in...
Emergence de new ALK mutations at relapse of neuroblastoma
www.slideshare.net
Dr Gudrun Schleiermacher, MD PhD, Institut Curie, Paris France ASCO annual meeting ALK mutations at relapse Results (Sanger sequencing): Alk mutations Clinical information ALK mutation ALK Detection by Sanger Patient N° Age at diag (months) stage (INSS) Interval diagnosis- relapse ...
A Dilated Cardiomyopathy Revealing a Neuroblastoma: Which Link?:...
www.ingentaconnect.com
Gudrun Schleiermacher, MD, PhD,* and Daniel Orbach, MD*. Summary: Acute cardiac dysfunctions associated to neuroblastoma have rarely been reported.
Emergence de new ALK mutations at relapse of neuroblastoma
pdfslide.us
1. Emergence of new ALK mutations at relapse of neuroblastoma Gudrun Schleiermacher MD PhD Institut Curie, Paris JCO, in press 2. Background • Cancer :...
Pinpointing mutations in a relapsed children's cancer may lead to...
www.sciencedaily.com
Researchers studying the pediatric cancer neuroblastoma have detailed how cancer-driving mutations evolve during chemotherapy, and they hope to exploit this...
Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations |...
www.nature.com
John Maris, Jan Molenaar, Gudrun Schleiermacher and colleagues performed whole-genome sequencing of 23 paired diagnostic and relapsed neuroblastomas, showing...
Somatic and germline activating mutations of the ALK kinase receptor...
www.nature.com
This is one of four papers in this issue that identifies mutations in the tyrosine kinase receptor ALK in neuroblastoma, the most frequent childhood cancer....
Gudrun Schleiermacher — ASN Events
anr-2016.p.asnevents.com.au
Gudrun Schleiermacher Advances in Neuroblastoma Research Congress Days; Sunday, 19th June · Monday, 20th June · Tuesday, 21st June ...
European Low and Intermediate Risk Neuroblastoma Protocol - Full Text...
clinicaltrials.gov
Study Chair: Gudrun Schleiermacher, Institut Curie Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood ...
Clinical Characteristics and Outcome of Patients with Neuroblastoma...
plos.figshare.com
... Peuchmaur Jean Michon Olivier Delattre Gudrun Schleiermacher ... features of those of a group of NBs MYCN amplified (Group 3, n = 22).
Advisory Board Europe/Russia : Advances in Neuroblastoma Research...
www.anrmeeting.org
Website for the bi-annual Advances in Neuroblastoma Research Association Meetings
Altmetric – Relapsed neuroblastomas show frequent RAS-MAPK pathway...
www.altmetric.com
... Janoueix-Lerosey, Daniela S Gerhard, Huib N Caron, Olivier Delattre, Javed Khan, Rogier Versteeg, Gudrun Schleiermacher, Jan J Molenaar, John M Maris.
Genomic Profiles of Neuroblastoma Associated With Opsoclonus...
portal.research.lu.se
... Claudia Pasqualini; Dominique Valteau-Couanet; Dominique Plantaz; Jean Michon; Olivier Delattre; Marc Tardieu; Gudrun Schleiermacher.
Clonal heterogeneity in neuroblastoma:reconstructing ...f1000research.com › Browse
f1000research.com
Access the original poster in full on F1000Research: Clonal heterogeneity in neuroblastoma: reconstructing tumoral architecture from WGS data
Emergence of new ALK mutations at relapse of neuroblastoma - PubMed
pubmed.ncbi.nlm.nih.gov
In neuroblastoma, subclonal ALK mutations can be present at diagnosis with subsequent clonal expansion at relapse. Given the potential of ALK-targeted therapy,...
Emergence of new ALK mutations at relapse of neuroblastomalib.ugent.be › pug01:
lib.ugent.be
Gudrun Schleiermacher, Niloufar Javanmardi, Virginie Bernard, Quentin Leroy, Julie Cappo and 18 more (2014) JOURNAL OF CLINICAL ONCOLOGY.
European association involved in the research and care of children...
www.siopen.net
European association involved in the research and care of children with neuroblastoma - SIOPEN
Deep sequencing identifies new ALK mutations at neuroblastoma relapse...
healthylivingmagazine.us
... be considered on diagnostic samples," Dr. Gudrun Schleiermacher of the Institut Curie in Paris and her colleagues write in the Journal of Clinical Oncology, ...
Gene expression profiling of 1p genes in neuroblastomago.gale.com › i.do
go.gale.com
Author(s): Isabelle Janoueix-Lerosey [1]; Eugene Novikov [1]; Marta Monteiro [1]; Nadège Gruel [1]; Gudrun Schleiermacher [1]; Béatrice Loriod [2]; Catherine ...
Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor...
academic.oup.com
AbstractBackground. Neuroblastoma is characterized by substantial clinical heterogeneity. Despite intensive treatment, the survival rates of high-risk neuroblas
Gale Academic OneFile - Document - Heterogeneity of neuroblastoma...
go.gale.com
... Grossetête-Lalami [3]; Sylvain Baulande [4]; Gudrun Schleiermacher [3, 16, cell lines or in both hNCC lines ( n = 5,975) identified two distinct groups (Fig.
Meetings : ANR : Advances in Neuroblastoma Research ...www.anrmeeting.org › meetings-2...
www.anrmeeting.org
Workshop: New Biomarker Technologies - Gudrun Schleiermacher Title: Clinical Applications of Circulating Tumor DNA Studies: On Your Mark, Get Set, or Go?
Predicting outcomes for children with neuroblastoma using a ...moh-it.pure.elsevier.com › predictin...
moh-it.pure.elsevier.com
... Olivier Delattre, Gudrun Schleiermacher, Jean Michon, Valérie Combaret ... and were profiled in the largest neuroblastoma patient series (n=579) to date ...
Predicting outcomes for children with neuroblastoma using a...
www.infona.pl
... Bruno De Bernardi, Rosa Noguera, Marta Piqueras, Adela Cañete, Victoria Castel, Isabelle Janoueix-Lerosey, Olivier Delattre, Gudrun Schleiermacher, .
Alle Infos zum Namen "Gudrun Schleiermacher"
Verwandte Suchanfragen zu Gudrun Schleiermacher
| Rogier Versteeg Ruth Ladenstein Angela Bellini | Katia Mazzocco Dieter Hayn |
Personen Vorname "Gudrun" (15532) Name "Schleiermacher" (98) |
sortiert nach Relevanz / Datum